My second article as a featured writer for MESO-Rx got published today. The article serves as a primer on selective androgen receptor modulators (SARMs). I discuss the goal of developing SARMs, how they are supposed to work at the molecular level, and highlight what might have contributed to none of them having being approved by the Food and Drug Administration (FDA) after 20 years of research.
My article about SARMs on MESO-Rx
